Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
In the latest session, Elevation Oncology Inc (NASDAQ: ELEV) closed at $0.52 down -3.69% from its previous closing price of $0.54. In other words, the price has decreased by -$3.69 from its previous closing price. On the day, 0.52 million shares were traded. ELEV stock price reached its highest trading level at $0.5525 during the session, while it also had its lowest trading level at $0.5224.
Ratios:
For a deeper understanding of Elevation Oncology Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 41.10 and its Current Ratio is at 41.10. In the meantime, Its Debt-to-Equity ratio is 0.38 whereas as Long-Term Debt/Eq ratio is at 0.38.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Piper Sandler on May 31, 2024, initiated with a Overweight rating and assigned the stock a target price of $10.
On May 14, 2024, Stephens started tracking the stock assigning a Overweight rating and target price of $8.
On March 01, 2024, JMP Securities started tracking the stock assigning a Mkt Outperform rating and target price of $7.JMP Securities initiated its Mkt Outperform rating on March 01, 2024, with a $7 target price.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ELEV now has a Market Capitalization of 30877394 and an Enterprise Value of -49055604.
Stock Price History:
Over the past 52 weeks, ELEV has reached a high of $5.83, while it has fallen to a 52-week low of $0.36. The 50-Day Moving Average of the stock is -38.45%, while the 200-Day Moving Average is calculated to be -80.51%.
Shares Statistics:
For the past three months, ELEV has traded an average of 1.22M shares per day and 789630 over the past ten days. A total of 59.11M shares are outstanding, with a floating share count of 49.99M. Insiders hold about 15.43% of the company’s shares, while institutions hold 89.08% stake in the company. Shares short for ELEV as of 1726185600 were 6264972 with a Short Ratio of 5.12, compared to 1723680000 on 6401542. Therefore, it implies a Short% of Shares Outstanding of 6264972 and a Short% of Float of 11.1999996.
